Posts

How plausible may be a conference on IP (and regulatory) exclusivity? Sufficiently

Fordham 27 (Report 8): Second Medical Use/Plausibility

The Opinion of the Advocate General in the case C-443/17 (Abraxis case). A lost case for second medical indication SPCs?

Testing the boundaries of subjectivity: Infringement of Swiss-type claims in Warner-Lambert v Actavis